Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2012 | 12-2011 | |
Operating Expenses | 2,789 | 0 |
Operating Income | -2,789 | N/A |
Other Income | -803 | 0 |
Pre-tax Income | -3,592 | 0 |
Net Income Continuous | -3,592 | N/A |
Net Income | $-3,592 | $N/A |
EPS Basic Total Ops | -3.87 | N/A |
EPS Basic Continuous Ops | -3.72 | N/A |
EPS Diluted Total Ops | -3.87 | N/A |
EPS Diluted Continuous Ops | -3.72 | N/A |
EBITDA(a) | $-2,789 | $N/A |